Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Shilpa Medicare to acquire 30.4% stake in Spain's Gate2Brain with €7 million investment
The global glioblastoma treatment market is estimated at approximately $3 billion in 2025 and is projected to exceed $6 billion by 2035. The pediatric brain tumour market is estimated at around $1.5 billion, while the market for DIPG therapies is expected to reach nearly $1.2 billion by 2035.
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns
The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approval for semaglutide injections. A diabetes patient raised concerns about the drug's delivery system, alleging it deviates from global standards and poses health risks. The court has directed the CDSCO to consider the patient's representation within two months.

BofA sees domestic growth, Semaglutide opportunity driving pharma in FY27
Neha Manpuria, Senior Analyst - Pharma, Healthcare at BofA Global Research, says semaglutide launches could emerge as a key growth driver for Indian pharma companies in FY27.

Top Gainers & Losers on June 2: Newgen Software Tech, Concord Biotech, TCS, HFCL, NMDC among top gainers
On June 2, Indian stocks rebounded with benchmarks up over 0.5%, driven by technology shares. The Nifty 50 and Sensex closed at 23,506 and 74,692, respectively. However, India fell to seventh in global market capitalisation due to overseas selling and weak earnings growth.
Global macro woes take holidayers in different direction
Indian travelers are opting for short-haul international trips to Southeast Asia and Australia, or domestic getaways this summer. This shift away from the US and Europe is driven by significantly higher airfares and flight disruptions. Destinations like the Philippines, Thailand, and Malaysia are seeing increased popularity, while bookings for traditional Western routes have softened.
Government revises windfall tax on fuel exports from June 1
New windfall tax rates on fuel exports take effect from June 1, 2026. Taxes are back on diesel and aviation turbine fuel after a period of nil levies. Petrol exports will also attract a duty. These revisions reflect changes in global oil prices and refiner margins. The government reviews these rates fortnightly.
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta
Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant global product filings over the next three years. Cipla will also expand its presence in North America and Europe. Innovation is expected to contribute a meaningful portion of revenues in the coming decade.

Pharma stock declares 18% final dividend along with Q4 results 2026
Lincoln Pharmaceuticals announced a final dividend of ₹1.80 per share for FY26, reporting a net profit of ₹11.63 crore in Q4FY26. The company aims for ₹1,000 crore revenue in three years, focusing on expanding its product portfolio and global presence.
Health services, medical education expansion to be driven by modern tech: Yogi Adityanath
Uttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding services. Medical colleges and nursing institutions will be strengthened with modern technology. Ayushman Yojana support for the poor was highlighted. Efforts are underway to enhance emergency services and control communicable diseases.
India’s scorching nights strain power grid and threaten health
India faces a dual threat from dangerously hot summers and increasingly sweltering nights, exacerbated by global warming and urban heat islands. This sustained heat strains both people and power infrastructure, leading to record energy demand and widespread blackouts, particularly impacting vulnerable populations.
Petrol, diesel prices hiked by Rs 7.5 per litre since Iran war: Here’s how it will impact your daily life
Fuel prices are rising again, making travel and goods more expensive. This impacts transporters, supply chains, and household budgets. Oil Marketing Companies are seeing stock rallies. The government faces a challenge balancing OMCs' financial health with consumer impact. Global events continue to influence fuel costs.
Blue Jet Healthcare gains 8% post Q4; analysts split on near-term prospects
Emkay Global has retained its 'Reduce' rating, while Motilal Oswal has maintained its 'Buy' stance, reflecting contrasting expectations on recovery in key business segments and the margin trajectory